Orphazyme ApS (LLC) Clinical Trial Updates for Niemann-Pick Type C Disease ~ September 8th, 2014
Dear NNPDF Families and Friends,
The National Niemann-Pick Disease Foundation is pleased to share with you the following announcement received from Orphazyme ApS of an upcoming clinical trial for Niemann-Pick Disease Type C. Orphazyme ApS (Copenhagen, Denmark) develops new therapies for the treatment of rare and genetic diseases.
As more information becomes available we will continue to update the NNPDF web site, as well as, our social media sites. As a reminder you can always find the latest updates on all Niemann-Pick Disease related topics at the Foundation’s Newline web page: https://www.nnpdf.org/NewsLinePage.html